MET and neoplasm: In the late stages of breast cancer also, c-Met promotes metastases by having vascular reprogramming and inflammatory cytokine upregulation [51], inflammation-related cytokine tumor necrosis factor-alpha (TNF-α) in tumor invasion [52].